Countdown to Baxter (BAX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Core Insights - Baxter International (BAX) is expected to report quarterly earnings of $0.78 per share, a 14.7% increase year-over-year, with revenues forecasted at $3.84 billion, reflecting a 3.6% year-over-year increase [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions to stock performance [2] - Analysts' consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in expectations [1] Key Metrics Projections - Analysts estimate 'Net Sales- Front Line Care' at $299.88 million, a decrease of 0.4% year-over-year [4] - 'Net Sales- Other' is projected to be $15.92 million, reflecting a decline of 6.4% year-over-year [4] - 'Net Sales- Advanced Surgery' is expected to reach $266.68 million, indicating a growth of 4.6% year-over-year [4] Pharmaceuticals and Geographic Sales - 'Net Sales- Pharmaceuticals' is anticipated to be $613.55 million, showing a year-over-year increase of 5.8% [5] - 'Net Sales- Acute Therapies- U.S.' is projected at $74.76 million, a 13.3% increase from the previous year [5] - 'Geographic Net Sales- International' is expected to be $2.01 billion, reflecting a 3.4% increase year-over-year [5] Additional Sales Insights - 'Net Sales- Pharmaceuticals- U.S.' is estimated at $210.04 million, a 7.7% increase year-over-year [6] - 'Net Sales- Pharmaceuticals- International' is projected to reach $417.62 million, indicating an 8.5% increase from the prior year [6] - 'Net Sales- Advanced Surgery- U.S.' is expected to be $144.46 million, reflecting a 3.9% increase year-over-year [6] Other Sales Projections - 'Net Sales- Advanced Surgery- International' is forecasted at $121.45 million, a 4.7% increase year-over-year [7] - 'Net Sales- Other- U.S.' is projected to be $10.59 million, indicating an 11.7% decline year-over-year [7] - 'Net Sales- Other- International' is expected to reach $4.96 million, reflecting a decrease of 0.8% year-over-year [7] Stock Performance - Over the past month, Baxter shares have recorded a return of +0.1%, compared to the Zacks S&P 500 composite's -0.5% change [7]